Skip to content

Nutritional education effect on metabolic syndrome in patients with spinal cord inury

Assessment of nutritional education of standard low fat and low calorie diets on reduction of risk factors of metabolic syndrome in comparison with control group in patients with chronic spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201406215968N3
Enrollment
52
Registered
2014-08-07
Start date
2014-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Metabolic Syndrom. Condition 2: Spinal Cord Injury. Metabolic syndrome is a group of conditions that put you at risk for heart disease and diabetes. These conditions are high blood pressure high blood sugar levels high levels of triglycerides, a type of fat, in your blood low levels of hdl Injuries to the spinal cord (S24.0 and S24.1) refer to the cord level and not bone level injury, and can affect nerve roots at and below the level given

Interventions

Intervention 1: Intervention group will receive standard nutritional care plus specific nutritional education (low fat, low calorie diets) for 6 months. Intervention 2: Control group will receive stan
Lifestyle
Intervention group will receive standard nutritional care plus specific nutritional education (low fat, low calorie diets) for 6 months
Control group will receive standard nutritional care

Sponsors

Brain and Spinal Injury Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria are : Age above 18; Minimum time since injury of 2 years ; Traumatic injury; BMI higher than 22. Exclusion criteria are: Pregnancy; lactation; Previous history of diseases that affect bone metabolism such as Paget’s disease; primary hyperparathyroidism; osteomalacia; Clinical hypocalcemia; hypophosphatemia; Consumption of medications like calcitonin, floride, calciteriol, heparin, phenytoin, phenobarbital and estrogen in the past 6 months; Consumption of bisphosphonates or corticosteroids for more than 6 months; previous history of consumption of methotrexate or floride; Recent consumption of medications (either synthetic or herbal) with anti-platelet activity, tetracyclin, magnesium or zinc supplements; Previous history of liver diseases or any symptoms indicating liver diseases based on screening laboratory tests; Previous history of fracture of femur or spine in the past year (unrelated to the trauma); Previous history of allergy to fish or fish oil; Anemia (confirmed by hemoglobin or hematocrit measurement); Hypertension

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cholesterol. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;Triglyceride. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;Low Density Lipoprotein (LDL). Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;High Density Lipoprotein (HDL). Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.;Body Mass Index (BMI). Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Measring weight and height and calculation of BMI.;Waist circumstance. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Direct measuremnet.;Fasting Blood Glucose. Timepoint: At the baseline and then after 3 and 6 months. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadis Sabour

Brain and Spinal Injury Research Center

hsabour@farabi.tums.ac.ir+98 21 6658 1560

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 1, 2026